Epinephrine
Product No. AG002K · Size: 3x0.5 mL (1mM)
Aggregation 
Description
Investigation of platelet aggregation induced by epinephrine.
Intended use
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma).
Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Related Products
Name
Insert
MSDS